Transplant Failure
12
2
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (12)
HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection
Tacrolimus Blood Concentration and Transplant-related Outcomes in Pediatric HSCT Recipients
The Transplant Cohort of the German Center for Infection Research
Evaluation of APOL1 Gene Variants in Kidney Donors and Their Impact on Long-term Renal Function in Donors and Recipients
NCAMR-CAMR Allosure Study
MuLtimodality EvaluatiOn of aNtibody mEdiated Damage in Heart Transplantation (LEONE-HT)
T-lymphocytes CD8+/HLA-DR+ and Acute Rejection After Lung Transplantation
Breast Reconstruction in Previously Irradiated Breast
Adjuvant Radiotherapy's Effect on One and Two Stages Prosthetic Breast Reconstruction and on Autologous Reconstruction
The Effects of Microbiota Composition on Immunosuppression Protocols in Transplantation
Blood-Bile Ratio Tacrolimus After Liver Transplantation
Associated Balance of Risk Score - Comprehensive Complication Index for the Prediction of Post-transplant Survival